Growth Opportunities for Global Computer-aided Diagnosis (CAD) in Breast Cancer Screening
Artificial Intelligence and Deep Learning Support Better Clinical Outcomes and Fuel Growth Pipeline
07-Feb-2022
North America
Market Research
PC50-01-00-00-00
HC03499-NA-MT_26241
This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due to their use as a primary tool for breast cancer detection. These segments are followed by MRI-CAD, which is mainly used as an adjunct to both mammography and ultrasound in breast imaging.
Analysis of the competitive landscape indicates that the top companies accounted for a combined 95% of the total CAD in breast cancer screening market for 2021. Offering AI-enabled CAD solutions is a growth area observed in the market. Given the market dynamics, trends, and competitive nature, it is important for industry stakeholders to have an overall perspective of the technology segments and workflow. This report offers insightful analysis of CAD in breast cancer screening in the form of a global forecast, regional and technological forecasts and analyses, benchmarking of top competitors, and key growth opportunities for industry participants.
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Global Computer-aided Diagnosis (CAD) in Breast Cancer Screening Market
Growth Opportunities Fuel the Growth Pipeline Engine™
Main Highlights
CAD in Breast Cancer Screening Scope of Analysis
Market Overview
Market Segmentation by Technology
Key Competitors by Region for CAD in Breast Cancer Screening
Key Growth Metrics for CAD in Breast Cancer Screening
Growth Drivers for CAD in Breast Cancer Screening
Growth Restraints for CAD in Breast Cancer Screening
Forecast Methodology and Assumptions
Revenue Forecast
Global Revenue Forecast Analysis
Revenue Forecast by Segment
Mammo-CAD Revenue Forecast
Mammo-CAD—Revenue Forecast Analysis
Ultrasound-CAD Revenue Forecast
Ultrasound CAD—Revenue Forecast Analysis
PET/CT-CAD Revenue Forecast
PET/CT-CAD—Revenue Forecast Analysis
MRI-CAD Revenue Forecast
MRI-CAD—Revenue Forecast Analysis
Revenue Forecast by Region
Revenue Forecast Analysis by Region
Pricing Trends Forecast by Product, CAD in Breast Cancer Screening
Pricing Trends and Forecast Analysis
Competitive Environment
Adoption Curve of CAD in Breast Cancer Screening by Product Type
Top Competitor—Hologic
Top Competitor—iCAD
Revenue Share
Revenue Share Analysis
Business Model Overview—CAD in Breast Cancer Screening
Clinical End-user Perspective
Factors to Consider for Seamless Integration with Workflow—CAD in Breast Cancer Screening Market
Key Growth Metrics for CAD in Breast Cancer Screening Market, North America
CAD in Breast Cancer Screening Market Dynamics, North America
Revenue Forecast, North America
Percent Revenue by Segment, North America
Revenue Forecast by Segment Analysis, North America
Revenue Forecast by Segment Discussion, North America (continued)
Competitive Environment, North America
Competitive Environment Analysis, North America
Key Growth Metrics for CAD in Breast Cancer Screening Market, Europe
CAD in Breast Cancer Screening Market Dynamics, Europe
Revenue Forecast, Europe
Percent Revenue by Segment, Europe
Revenue Forecast by Segment Analysis, Europe
Revenue Forecast by Segment Analysis, Europe (continued)
Competitive Environment, Europe
Competitive Environment Analysis, Europe
Key Growth Metrics for CAD in Breast Cancer Screening Market, APAC
CAD in Breast Cancer Screening Market Dynamics, APAC
Revenue Forecast, APAC
Percent Revenue by Segment, APAC
Revenue Forecast by Segment Analysis, APAC
Revenue Forecast by Segment Analysis, APAC (continued)
Competitive Environment, APAC
Competitive Environment Analysis, APAC
Key Growth Metrics for CAD in Breast Cancer Screening Market, ROW
CAD in Breast Cancer Screening Market Dynamics, ROW
Revenue Forecast, ROW
Percent Revenue by Segment, ROW
Revenue Forecast by Segment Analysis, ROW
Revenue Forecast by Segment Analysis, ROW (continued)
Competitive Environment, ROW
Competitive Environment Analysis, ROW
Growth Opportunity Summary
Growth Opportunity 1—Opportunities with Breast Cancer Screening Using Mobile Mammography and Mobile Ultrasound
Growth Opportunity 1—Opportunities with Breast Cancer Screening Using Mobile Mammography and Mobile Ultrasound (continued)
Growth Opportunity 2—AI Coupled with DL to Support Better Clinical Outcomes in Breast Cancer Screening
Growth Opportunity 2—AI Coupled with DL to Support Better Clinical Outcomes in Breast Cancer Screening (continued)
Growth Opportunity 3—Utilizing CAD Triage (CADt) to Reduce Human Error and Increase Efficiency in Breast Imaging
Growth Opportunity 3—Utilizing CAD Triage (CADt) to Reduce Human Error and Increase Efficiency in Breast Imaging (continued)
Growth Opportunity 4—Partnerships with OEMs Providing Breast Screening Systems to Gain a Wider Customer Base
Growth Opportunity 4—Partnerships with OEMs Providing Breast Screening Systems to Gain a Wider Customer Base (continued)
Growth Opportunity 5—Increase in Use of CAD in APAC to Bolster Clinical Adoption in the Region
Growth Opportunity 5—Increase in Use of CAD in APAC to Bolster Clinical Adoption in the Region (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
26 Oct 2026 | Global | Technology Research
Game-Changing Innovations Transforming Cardiovascular Care
The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interven...
23 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Implantable and Diagnostic Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantable.The issue features advanced medical devices such as single-breath-hold radiotherapy system, transcatheter system f...
16 Oct 2026 | Global | Market Research
Public Sector Healthcare Cloud Market, North America and Europe, 2026
Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...
16 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.